Literature DB >> 21443677

Estimating the potential pool of HIV-infected deceased organ donors in the United States.

B J Boyarsky1, E C Hall, A L Singer, R A Montgomery, K A Gebo, D L Segev.   

Abstract

Human immunodeficiency virus (HIV) is no longer a contraindication to transplantation. For HIV-infected patients, HIV-infected deceased donors (HIVDD) could attenuate the organ shortage and waitlist mortality. However, this practice would violate United States federal law. The goal of this study was to estimate the potential impact of legalizing transplantation of HIV-infected organs by quantifying the potential pool of HIVDD. Using Nationwide Inpatient Sample (NIS) data, HIV-infected deaths compatible with donation were enumerated. Using HIV Research Network (HIVRN) data, CD4 count, plasma HIV-1 RNA level, AIDS-defining illnesses and causes of death were examined in potential HIVDD. Using UNOS data, evaluated donors who later demonstrated unanticipated HIV infections were studied. From NIS, a yearly average of 534 (range: 481-652) potential HIVDD were identified, with 63 (range: 39-90) kidney-only, 221 (range: 182-255) liver-only and 250 (range: 182-342) multiorgan donors. From HIVRN, a yearly average of 494 (range: 441-533) potential HIVDD were identified. Additionally, a yearly average of 20 (range: 11-34) donors with unanticipated HIV infection were identified from UNOS. Deceased HIV-infected patients represent a potential of approximately 500-600 donors per year for HIV-infected transplant candidates. In the current era of HIV management, a legal ban on the use of these organs seems unwarranted and likely harmful. ©2011 The Authors Journal compilation©2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21443677      PMCID: PMC3110583          DOI: 10.1111/j.1600-6143.2011.03506.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  35 in total

1.  Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 study in collaboration with the Mortalité 2005 survey, ANRS EN19).

Authors:  E Rosenthal; D Salmon-Céron; C Lewden; V Bouteloup; G Pialoux; F Bonnet; M Karmochkine; T May; M François; C Burty; E Jougla; D Costagliola; P Morlat; G Chêne; P Cacoub
Journal:  HIV Med       Date:  2009-02-15       Impact factor: 3.180

2.  Effective communication of standard errors and confidence intervals.

Authors:  Thomas A Louis; Scott L Zeger
Journal:  Biostatistics       Date:  2008-06-10       Impact factor: 5.899

Review 3.  Liver and kidney transplantation in HIV-infected patients.

Authors:  Clara C Tan-Tam; Lynda A Frassetto; Peter G Stock
Journal:  AIDS Rev       Date:  2009 Oct-Dec       Impact factor: 2.500

4.  Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.

Authors:  Gregory M Lucas; Bryan Lau; Mohamed G Atta; Derek M Fine; Jeanne Keruly; Richard D Moore
Journal:  J Infect Dis       Date:  2008-06-01       Impact factor: 5.226

5.  Spectrum of chronic kidney disease in HIV-infected patients.

Authors:  L J Campbell; F Ibrahim; M Fisher; S G Holt; B M Hendry; F A Post
Journal:  HIV Med       Date:  2009-02-15       Impact factor: 3.180

6.  Trends in mortality and causes of death among women with HIV in the United States: a 10-year study.

Authors:  Audrey L French; Susan H Gawel; Ronald Hershow; Lorie Benning; Nancy A Hessol; Alexandra M Levine; Kathryn Anastos; Michael Augenbraun; Mardge H Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-01       Impact factor: 3.731

Review 7.  End-stage renal disease and kidney transplant in HIV-infected patients.

Authors:  Deirdre Sawinski; Barbara Murphy
Journal:  Semin Nephrol       Date:  2008-11       Impact factor: 5.299

8.  Renal transplant in HIV-positive patients: long-term outcomes and risk factors for graft loss.

Authors:  Jayme E Locke; Robert A Montgomery; Daniel S Warren; Aruna Subramanian; Dorry L Segev
Journal:  Arch Surg       Date:  2009-01

Review 9.  Solid organ transplantation in HIV-infected individuals: an update.

Authors:  Shirish Huprikar
Journal:  Rev Med Virol       Date:  2009-11       Impact factor: 6.989

10.  HIV-1 superinfection in the antiretroviral therapy era: are seroconcordant sexual partners at risk?

Authors:  Mary S Campbell; Geoffrey S Gottlieb; Stephen E Hawes; David C Nickle; Kim G Wong; Wenjie Deng; Thomas M Lampinen; Nancy B Kiviat; James I Mullins
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more
  37 in total

1.  The Challenges and Promise of HIV-Infected Donors for Solid Organ Transplantation.

Authors:  Aaron Richterman; Emily Blumberg
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

2.  Kidney infection with HIV-1 following kidney transplantation.

Authors:  Peter G Stock
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

3.  Opportunities and Challenges for Kidney Donation from and to HIV-Positive Individuals.

Authors:  Sindhu Chandran; Peter G Stock
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-23       Impact factor: 8.237

4.  Hopeful act: a rebel transplants organs from HIV-positive donors.

Authors:  Sara Reardon
Journal:  Nat Med       Date:  2014-10       Impact factor: 53.440

5.  Organs from deceased donors with false-positive HIV screening tests: An unexpected benefit of the HOPE act.

Authors:  Christine M Durand; Samantha E Halpern; Mary G Bowring; Gilad A Bismut; Oyinkansola T Kusemiju; Brianna Doby; Reinaldo E Fernandez; Charles S Kirby; Darin Ostrander; Peter G Stock; Shikha Mehta; Nicole A Turgeon; David Wojciechowski; Shirish Huprikar; Sander Florman; Shane Ottmann; Niraj M Desai; Andrew Cameron; Allan B Massie; Aaron A R Tobian; Andrew D Redd; Dorry L Segev
Journal:  Am J Transplant       Date:  2018-07-23       Impact factor: 8.086

Review 6.  Moving from the HIV Organ Policy Equity Act to HIV Organ Policy Equity in action: changing practice and challenging stigma.

Authors:  Brianna L Doby; Aaron A R Tobian; Dorry L Segev; Christine M Durand
Journal:  Curr Opin Organ Transplant       Date:  2018-04       Impact factor: 2.640

7.  Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.

Authors:  V Martel-Laferrière; A Michel; S Schaefer; S Bindal; K Bichoupan; A D Branch; S Huprikar; T D Schiano; P V Perumalswami
Journal:  Transpl Infect Dis       Date:  2015-06-15       Impact factor: 2.228

8.  Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers.

Authors:  Sarah E Van Pilsum Rasmussen; Mary Grace Bowring; Ashton A Shaffer; Macey L Henderson; Allan Massie; Aaron A R Tobian; Dorry L Segev; Christine M Durand
Journal:  Clin Transplant       Date:  2018-08-31       Impact factor: 2.863

Review 9.  Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation.

Authors:  Stephen E Congly; Karen E Doucette; Carla S Coffin
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 10.  Update on kidney transplantation in human immunodeficiency virus infected recipients.

Authors:  Khaled Nashar; Kalathil K Sureshkumar
Journal:  World J Nephrol       Date:  2016-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.